By IDSE News Staff
A single dose of a novel oral antibiotic called zoliflodacin (Innoviva Specialty Therapeutics) was found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea, according to the Global Antibiotic Research and Development Partnership (GARDP), the study sponsor.
Zoliflodacin has a unique mechanism of action in the way that it inhibits a crucial bacterial enzyme called type II topoisomerase, which is essential for bacterial function and